Skip to main content
Toggle navigation
Login
Search
Home
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Favorite
Print
InnoSphere
TOWN HALL WITH THE FDA (Non-CME)
During Trial Design, Balancing Surrogate Markers With Patient-Reported Outcomes as Trial Endpoints
Monday, November 3, 2025
8:07am - 8:14am
PT
Speaker(s)
DB
Donna Buckley, MD
Disclosure(s): No financial relationships to disclose
Disclosure(s):
Donna Buckley, MD
: No financial relationships to disclose